2018
Jeff Aronin is Named Innovator of the Year by Best in Biz
Jeff Aronin is Named Innovator of the Year by Best in Biz With its highest honor, a Gold level award, Best in Biz recognizes Jeff [...]
Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle Creek Pharma
Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle Creek Pharma Paragon organizes new investment from Fidelity Management & Research Company and [...]
Crain’s Chicago Business: “Chicago-based Biotech Incubator Raises $71.8 Million”
Crain’s Chicago Business: “Chicago-based Biotech Incubator Raises $71.8 Million” October 19, 2019 – Paragon Biosciences CEO Jeff Aronin spoke with Crain’s Chicago Business on his role [...]
Jeff Aronin Named One of the 20 Most Influential Leaders in Healthcare for 2018
Jeff Aronin Named One of the 20 Most Influential Leaders in Healthcare for 2018 Paragon CEO Jeff Aronin Recognized by Insights Care Magazine as “Innovative [...]
Paragon Biosciences Announces Skyline Biosciences as the Newest Addition to Its Growing Portfolio of Companies
Paragon Biosciences Announces Skyline Biosciences as the Newest Addition to Its Growing Portfolio of Companies CHICAGO – August 21, 2018 – Paragon Biosciences (Paragon) today [...]
Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome
Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome CHICAGO – August 14, 2018 – Biopharmaceutical company Emalex Biosciences (Emalex), the [...]
